Cargando…
Commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in DMIS contributing for the increased bioavailability of tramadol?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602013/ https://www.ncbi.nlm.nih.gov/pubmed/23497476 http://dx.doi.org/10.1186/2008-2231-21-23 |
_version_ | 1782263516716072960 |
---|---|
author | Srinivas, Nuggehally R |
author_facet | Srinivas, Nuggehally R |
author_sort | Srinivas, Nuggehally R |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-3602013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36020132013-03-20 Commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in DMIS contributing for the increased bioavailability of tramadol? Srinivas, Nuggehally R Daru Letter to the Editor BioMed Central 2013-03-15 /pmc/articles/PMC3602013/ /pubmed/23497476 http://dx.doi.org/10.1186/2008-2231-21-23 Text en Copyright ©2013 Srinivas; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editor Srinivas, Nuggehally R Commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in DMIS contributing for the increased bioavailability of tramadol? |
title | Commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in DMIS contributing for the increased bioavailability of tramadol? |
title_full | Commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in DMIS contributing for the increased bioavailability of tramadol? |
title_fullStr | Commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in DMIS contributing for the increased bioavailability of tramadol? |
title_full_unstemmed | Commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in DMIS contributing for the increased bioavailability of tramadol? |
title_short | Commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in DMIS contributing for the increased bioavailability of tramadol? |
title_sort | commentary on: “study of the pharmacokinetic changes of tramadol in diabetic rats” is the handicapped renal pathway in dmis contributing for the increased bioavailability of tramadol? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602013/ https://www.ncbi.nlm.nih.gov/pubmed/23497476 http://dx.doi.org/10.1186/2008-2231-21-23 |
work_keys_str_mv | AT srinivasnuggehallyr commentaryonstudyofthepharmacokineticchangesoftramadolindiabeticratsisthehandicappedrenalpathwayindmiscontributingfortheincreasedbioavailabilityoftramadol |